Dispensing of medications compounded at traditional compounding pharmacies to multiple patients is not necessarily prohibited through any explicit language of the law, nor is it permitted; the NYSVMS and the AVMA are seeking clarification from the FDA on this issue.  However, there is a type of compounding pharmacy -- a 503B outsourcing facility -- that can compound medications for practitioners as "office stock."  In 2014, New York State adopted legislation authorizing 503B outsourcing facilities to operate within the state, but the situation is complex.


Please refer to our detailed article:  https://nysvms.freshdesk.com/support/solutions/articles/35000088434-503-compounding-facilities-and-office-use-compounded-medications.